Skip to main content
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
83.94
+0.13 (0.16%)
Dec 5, 2025, 4:00 PM EST - Market closed

Haemonetics Revenue

Haemonetics had revenue of $327.32M in the quarter ending September 27, 2025, a decrease of -5.27%. This brings the company's revenue in the last twelve months to $1.33B, down -2.45% year-over-year. In the fiscal year ending March 29, 2025, Haemonetics had annual revenue of $1.36B with 3.95% growth.

Revenue (ttm)
$1.33B
Revenue Growth
-2.45%
P/S Ratio
3.08
Revenue / Employee
$439,249
Employees
3,023
Market Cap
3.93B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 29, 20251.36B51.77M3.95%
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020 Pro Pro Pro
Mar 30, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Apr 1, 2017 Pro Pro Pro
Apr 2, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

HAE News

More News